Commentary on Alternative Therapies and Life Style Interventions for Obese Individuals with Type 2 Diabetes

In Patient Engagement By Dr. Charles Shively / September 18, 2017

With obesity worldwide reaching pandemic levels (recent global research indicates over 2 billion individuals are either obese or overweight…one-third of the world population), it has pervaded countries with greatly different cultures and nutritional habits. Many different interventions have been offered and researched in the past ten years, with some intervention approaches being significantly better than others. As practitioners look for alternative therapies for patients who are obese with Type 2 Diabetes and view best practice approaches available, the current controversy using the traditional Metformin and GLP 1 Receptor Agonists (Byetta, Bydureon, Tanzaum, Trulicity and Victoza) has caused many practitioners to consider alternative therapies. Additionally, in the US alone, one-third of the 323 milllion population (2016) is classified as diabetic or pre-diabetic by the CDC (US Centers for Disease Control and Prevention). Read more

Personalized Therapeutics through Pharmacogenomics

In Patient Engagement By Dr. Charles Shively / February 8, 2017

Introduction Most healthcare professionals are aware of the emerging field of pharmacogenomics. Many are not aware however that it is nearing its 15th year of pursuit to combine the science of how drugs work (pharmacology) with the science of the human genome (genomics). Although the field of pharmacogenomics is still in its infancy with only limited use in select disease areas such as cancer, cardiovascular challenges, HIV, Alzheimer’s and asthma, the coordination between United States research centers is accelerating the pace and implementation in several new disease states. This approach to personalized medicine is a significant departure from previous drug development where the idea has existed that each drug works pretty much the same in every individual and where by exception over time is has been learned that many different aspects must be considered when a medication is provided to the end user. Read more

Are Wellness Teas Non-Pharmacologic Alternatives?

In Patient Engagement By Dr. Charles Shively / February 6, 2017

Recent market assessments indicate the current $7 Billion tea market will grow to $ 8 Billion by 2020—three years from now. Are teas and special herbal tea formulas actually effective in doing more than just supporting overall health? Can certain teas actually effect healing? The answer is YES! Read more

What Do Pediatric and Geriatric Patients Have In Common?

In Patient Engagement By Dr. Charles Shively / February 26, 2015

PATIENT ENGAGEMENT Millennial mothers and elder caregivers know. When there is a need to provide odd-tasting medications to their children or age-challenged dependents, they go to their independent pharmacy ... and often use social media to send the success stories of how the adjusted taste improved adherence ...and re-tweet or re-pin their delight. Are you surprised that techno-elders who need comfortable tasting meds also have joined the social media? Who is the winner in these scenarios? Of course, it's the child, the mother, the elder and the independent pharmacy which provided the flavored medication. Read more

Personal Perspectives: The Value of Almased® in Brain Fatigue

In Patient Engagement By Dr. Charles Shively / November 10, 2014

Tired Brain? Brain Fatigue? Slow Brain? Brain Fog? Brain Sluggish? Brain fatigue. Tired brain. Fuzzy brain. Slow brain. Brain fog. Adrenal fatigue. Chronic fatigue syndrome. Exercise challenge? Writers challenge? Not knowing what James Brown, the R/B singer really meant when he sang "I feel good, knew that I would", that concept for many individuals applies to a personal perspective about the value of Almased® use. Read more

Pharmacists, Adherence and Almased: A Winning Triad Combination

In Patient Engagement By Dr. Charles Shively / November 8, 2014

The Adherence Action Agenda and Diabetes For years, pharmacists have acknowledged the guideline triad regarding prescription dispensing: Is there a known relationship between the patient, physician and pharmacist? Today, pharmacists have been challenged to support and advance a national agenda-The Adherence Action Agenda (A3)- following a report by the National Council on Patient Information and Education (NCPIE) in October of 2013. Read more

Primary Care and Pharmacy: Sooner or Later?

In Patient Engagement By Dr. Charles Shively / November 6, 2014

Primary Care IS Pharmacy! Who here senses…as I do…that pharmacy owners can effort ROI success by establishing primary care centers within their existing operations?  Are we “on the same page”? Read more

Believe It, Almased® Affects Permanent Weight Loss for People with Diabetes!

In Patient Engagement By Dr. Charles Shively / November 11, 2014

Believe what you read? The back of an Almased® sample packet has a number of statements that caused me…a pharmacist…to further investigate the product. Only after a thorough investigation (easy these days with the internet availability of credible studies), guess what? They are all true Read more